* StockInvest.us
uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
Unlock All Premium Features! Go Premium! Only $19.90/Month
Unlock the Top 5 candidates in every list
Unlock full Ultimate List Builder
Golden Star lists & Auto Portfolios
Possible Runners & Moving Average lists
Ad-free browsing
Save data in PDF
About ContraFect Corporation
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus bacteremia. The company also develops CF-296, an engineered lysin, used for treatment of the in... CFRX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
